Gabapentin Solution
NDC Package 86211-112-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Gabapentin solution is gabapentin is used with other medications to prevent and control seizures. This formulation utilizes a solution delivery system. Marketed by Jvet Pharmaceuticals Llc, this product is identified by NDC 86211-112 and is authorized under FDA application ANDA091286.

Identification & Billing

NDC Package Code
86211-112-01
Package Description
473 mL in 1 BOTTLE
Product Code
86211-112
11-Digit Billing Format
86211011201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Gabapentin
Non-Proprietary Name
Gabapentin
Substance Name
Gabapentin
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
GABAPENTIN 250 mg/5mL
Pharmacologic Class
Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)
Usage Information
Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Regulatory & Marketing

Labeler Name
Jvet Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA091286
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 86211-112-01 identifies a specific commercial package of 473 ml in 1 bottle of Gabapentin, a human prescription drug labeled by Jvet Pharmaceuticals Llc. This solution is formulated for oral use and contains gabapentin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jvet Pharmaceuticals Llc on December 15, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

How is this Jvet Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 86211011201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
86211-112-01
11-Digit CMS (5-4-2)
86211-0112-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.